FairValueLabs Valuation System Value Investment
KMB

Kimberly-Clark Corporation (KMB) Stock Analysis — Fair Value, Risk & Moat Rating

NMS · Consumer Defensive · Household & Personal Products

$96.75 Buy Zone 0.15 (0.2%) As of Apr 22, 2026 Not a buy/sell recommendation. See disclaimer.
Overall Verdict Safe Zone
3.31
Altman Z-ScoreSafe Zone
$112.38
Fair ValueBuy Zone (13.9%)
3.7
Moat RatingSolid moat · eroding
TL;DR · Audit Summary

Is Kimberly-Clark Corporation a safe investment right now?

Kimberly-Clark Corporation's Altman Z-Score of 3.31 places it in the safe zone. Our fair value estimate is $112.38 (Buy Zone). Moat rating: 3.7/5 stars.

Price Chart · KMB
Section 01 · Financial Health

Could Kimberly-Clark Corporation go bankrupt? Altman Z-Score analysis

3.31

Z-Score of 3.31 is above 3.0, indicating the company is financially healthy by this metric.

  • Below 1.8 — Distress Zone (high bankruptcy risk)
  • 1.8 to 3.0 — Gray Zone (elevated uncertainty)
  • Above 3.0 — Safe Zone (financially healthy)

What drives KMB's Z-Score?

Altman Z-Score components for KMB
ComponentFormulaValueWeightContribution
A · Working Capital / Total AssetsWC / TA-0.10621.2-0.13
B · Retained Earnings / Total AssetsRE / TA0.56211.40.79
C · EBIT / Total AssetsEBIT / TA0.1353.30.45
D · Market Cap / Total LiabilitiesMCap / TL2.07610.61.25
E · Revenue / Total AssetsRev / TA0.96191.00.96

How has KMB's financial health changed over time?

3.0 Safe1.8 Distress0.01.02.03.04.02022202320242025
KMB Z-Score history
YearZ-ScoreZone
20223.25Safe
20233.12Safe
20243.47Safe
20253.31Safe

Source: Calculated from KMB's latest 10-K filing on SEC EDGAR.

Section 02 · Fair Value Estimate

What is Kimberly-Clark Corporation actually worth?

FVL Fair Value$112.38
vs
Market Price$96.75
Buy Zone 13.9% Stock trades 13.9% below our estimated fair value of $112.38.

How we calculated this

FVL Valuation Model
InputValueSource
Predicted EPS (α)$6.65Proprietary blend of reported actuals + analyst consensus, weighted by α
Last Year EPS$6.07Annual report (SEC EDGAR)
Analyst Consensus EPS (This Year)$7.5314 analysts consensus
Trailing P/E19.9xCurrent market pricing
Fair P/E (β discount)16.9xTrailing PE adjusted by value discount factor β, hard-capped
Earnings Trend (γ)AcceleratingDirectional signal: predicted vs trailing EPS

Wall Street Reference: Analyst consensus target price is $114.86 (14 analysts). This is shown for reference only and is not used in our valuation model.

Source: Earnings data from SEC EDGAR filings. Market data via Yahoo Finance.

Section 03 · Competitive Moat

Does Kimberly-Clark Corporation have a durable competitive advantage?

★★★½☆
Solid moat · eroding

Moat rating: 3.7/5.

What makes up KMB's moat score?

ROIC Stability

★★★★☆

ROIC variability over the past decade. Score: 4/5.

Gross Margin Trend

★★★★☆

Gross margin trajectory over the past decade. Score: 4/5.

Switching Costs

★★★☆☆

Estimated customer lock-in based on margin level. Score: 3/5.

How stable is KMB's return on invested capital?

0%-5%6%16%27%38%2022202320242025
KMB ROIC history
YearROICTrend
202229.2%
202321.3%Declining
202432.6%Rising
202526.6%Declining

Source: ROIC calculated from SEC EDGAR filings.

Section 04 · Dividend Safety

Is Kimberly-Clark Corporation's dividend safe?

C Dividend Safety Grade
Yield5.2%
Payout Ratio103.7%
Consecutive Years42
5Y Growth Rate-22.4%

Can Kimberly-Clark Corporation afford its dividend?

Payout ratio is 103.7%. FCF covers the dividend 1.2x. 42 consecutive years of payments.

Section 05 · Financial Summary

Kimberly-Clark Corporation's key financial metrics

KMB financial summary
MetricLatest1Y Ago3Y AgoTrend
Revenue $16.4B $16.8B $20.2B Declining
Net Income $2.0B $2.5B $1.9B Stable
Free Cash Flow $1.6B $2.5B $1.9B Declining
Gross Margin 36.0% 37.4% 30.8% Rising
Section 06 · Lab Signals

Recent events that affect our KMB analysis

EARNINGS

KMB earnings report scheduled

Lab Impact

Upcoming report. Consensus EPS estimate: $1.93. Revenue estimate: $4.09B. Our current Fair Value: $112.38 — a significant beat or miss could shift this estimate.

ANALYST

KMB analyst consensus: 40% bullish (6 of 15 analysts)

Lab Impact

3 Strong Buy, 3 Buy, 8 Hold, 1 Sell, 0 Strong Sell. Consensus target: $114.86 (18.7% upside). Compare with our independent Fair Value: $112.38.

DIVIDEND

KMB paid $1.2800/share dividend

Lab Impact

Dividend Safety Grade: C. Payout ratio: 103.7%.

FILING

KMB filed annual report (10-K)

Lab Impact

Annual filing with full-year financials. Our Altman Z-Score, Moat, and Fair Value models are derived from this data. View on SEC EDGAR →

FILING

KMB filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

EARNINGS

KMB beat EPS estimates by 2.7%

Lab Impact

Reported EPS: $1.86 vs estimate $1.81. Earnings strength supports our Fair Value of $112.38 (16.2% above current price).

FILING

KMB filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

KMB filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

DIVIDEND

KMB paid $1.2600/share dividend

Lab Impact

Dividend Safety Grade: C. Payout ratio: 103.7%.

FILING

KMB filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

KMB filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

KMB filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

EARNINGS

KMB beat EPS estimates by 3.9%

Lab Impact

Reported EPS: $1.82 vs estimate $1.75. Earnings strength supports our Fair Value of $112.38 (16.2% above current price).

FILING

KMB filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

FILING

KMB filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

DIVIDEND

KMB paid $1.2600/share dividend

Lab Impact

Dividend Safety Grade: C. Payout ratio: 103.7%.

EARNINGS

KMB beat EPS estimates by 16.0%

Lab Impact

Reported EPS: $1.92 vs estimate $1.66. Earnings strength supports our Fair Value of $112.38 (16.2% above current price).

FILING

KMB filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

FILING

KMB filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

KMB filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

DIVIDEND

KMB paid $1.2600/share dividend

Lab Impact

Dividend Safety Grade: C. Payout ratio: 103.7%.

FILING

KMB filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

KMB filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

KMB filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

KMB filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

EARNINGS

KMB beat EPS estimates by 2.0%

Lab Impact

Reported EPS: $1.93 vs estimate $1.89. Earnings strength supports our Fair Value of $112.38 (16.2% above current price).

FILING

KMB filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

FILING

KMB filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

DIVIDEND

KMB paid $1.2600/share dividend

Lab Impact

Dividend Safety Grade: C. Payout ratio: 103.7%.

FILING

KMB filed annual report (10-K)

Lab Impact

Annual filing with full-year financials. Our Altman Z-Score, Moat, and Fair Value models are derived from this data. View on SEC EDGAR →

EARNINGS

KMB missed EPS estimates by 0.9%

Lab Impact

Reported EPS: $1.50 vs estimate $1.51. Our Fair Value of $112.38 may face downward pressure if the trend continues.

FILING

KMB filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

KMB filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

Section 07 · FAQ

Common questions about Kimberly-Clark Corporation

What is Kimberly-Clark Corporation stock price today?

Kimberly-Clark Corporation (KMB) stock price is $96.75 as of the latest market close, traded on the NASDAQ exchange.

What does Kimberly-Clark Corporation do?

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care products in the United States. It operates in two segments, North America and International Personal Care. The North America segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, facial and bathroom tissue, paper towels, napkins, wipers, tissue, towels, soaps and sanitizers, and other related products under the Huggies, Pull-Ups, Goodnites, Kotex, Poise, Depend, Kleenex, Scott, Cottonelle, Viva, Wypall , and other brand names.

What is Kimberly-Clark Corporation market cap?

Kimberly-Clark Corporation has a market capitalization of $32.11B, classifying it as a large-cap stock in the Consumer Defensive sector.

What sector and industry is KMB in?

Kimberly-Clark Corporation operates in the Consumer Defensive sector, specifically within the Household & Personal Products industry. It trades on the NASDAQ under the ticker symbol KMB.

Is KMB stock overvalued or undervalued?

Based on our valuation model, Kimberly-Clark Corporation trades 13.9% below our fair value estimate — potentially undervalued.

  • FairValueLabs Fair Value: $112.38
  • Current Price: $96.75
  • Valuation Zone: Buy Zone
What is KMB stock forecast and analyst target price?

Based on 14 Wall Street analysts, the consensus price target for Kimberly-Clark Corporation is $114.86, implying upside of 18.7% from the current price.

  • Analyst High Target: $162.00
  • Analyst Low Target: $90.00

Note: Analyst targets are shown for reference and are not used in our valuation model.

Is Kimberly-Clark Corporation revenue and earnings growing?

Here are the analyst consensus growth estimates for Kimberly-Clark Corporation:

  • Revenue growth (current year est.): 2.9%
  • EPS growth (current year est.): -0.0%
  • Revenue growth (next year est.): 3.6%
  • EPS growth (next year est.): 1.4%
What are Kimberly-Clark Corporation's key financial metrics?
MetricLatestTrend
Revenue$16.4BDeclining
Net Income$2.0BStable
Free Cash Flow$1.6BDeclining
Gross Margin36.0%Rising
What is KMB's P/E ratio?

The price-to-earnings ratio measures how much investors pay per dollar of earnings:

  • Trailing P/E (last 12 months): 19.9x
  • Forward P/E (next 12 months est.): 12.8x
  • FairValueLabs Fair P/E: 16.9x
How volatile is KMB stock?

Kimberly-Clark Corporation has a beta of 0.30, meaning it is less volatile than the broader market. A beta above 1.0 indicates higher price swings relative to the S&P 500, while below 1.0 suggests more stability.

How much cash and debt does Kimberly-Clark Corporation have?

Kimberly-Clark Corporation's balance sheet shows:

  • Total Cash: $774.0M
  • Total Debt: $7.58B
  • Net Cash Position: $-6.80B

A positive net cash position means the company holds more cash than debt, reducing financial risk.

What is Kimberly-Clark Corporation's free cash flow?

Kimberly-Clark Corporation generated $912.9M in trailing twelve-month free cash flow (from $2.78B in operating cash flow). Free cash flow represents the cash available for dividends, buybacks, and debt reduction after all capital expenditures.

Does Kimberly-Clark Corporation pay a dividend, and is it safe?

Yes, Kimberly-Clark Corporation pays a regular dividend. Here are the key metrics:

  • Dividend Yield: 5.2%
  • Payout Ratio: 103.7%
  • Consecutive Years Paid: 42
  • 5-Year Dividend Growth: -22.4%
  • FairValueLabs Safety Grade: C
Is Kimberly-Clark Corporation at risk of going bankrupt?

Kimberly-Clark Corporation's Altman Z-Score is 3.31, placing it in the safe zone (above 3.0) — bankruptcy risk is low. The Z-Score uses five balance sheet ratios to predict bankruptcy probability within two years.

Does Kimberly-Clark Corporation have a durable competitive advantage?

Kimberly-Clark Corporation scores 3.7/5 stars (Solid moat · eroding) in our moat analysis:

  • ROIC Stability: 4/5
  • Gross Margin Trend: 4/5
  • Switching Costs: 3/5

A score above 3.5 suggests meaningful pricing power and a defensible market position.

What is KMB's return on equity (ROE)?

Kimberly-Clark Corporation's return on equity is 126.6%. ROE measures how efficiently a company generates profits from shareholder equity. An ROE above 15% is generally considered strong, while below 10% may signal inefficiency.

How do I buy KMB stock?

KMB shares can be purchased through any brokerage account that provides access to the NASDAQ. Common steps:

  1. Open an account with a broker (e.g., Fidelity, Schwab, Interactive Brokers)
  2. Search for ticker symbol KMB
  3. Place a market or limit order for your desired number of shares

This is not investment advice. Always do your own research before buying any stock.

Is KMB a value stock or speculative?

FairValueLabs classifies Kimberly-Clark Corporation as Value Investment. It exhibits consistent profitability, reasonable valuation, and financial stability — characteristics of a traditional value investment.

Who is the CEO of Kimberly-Clark Corporation?

The current CEO of Kimberly-Clark Corporation is Mr. Michael D. Hsu.

What is KMB's earnings per share (EPS)?

Earnings per share measures the company's profit allocated to each outstanding share:

  • Trailing EPS (last 12 months): $4.86
  • Forward EPS (next 12 months est.): $7.59
  • Analyst consensus EPS (this year): $7.53
  • Analyst consensus EPS (next year): $7.63

FairValueLabs Disclaimer

All valuations, scores, ratings, and classifications on this page are produced by the FairValueLabs internal valuation system. They do not represent actual market value, guaranteed outcomes, or professional investment advice. These are analytical estimates for educational and research purposes only.

This is not financial advice. All data is sourced from SEC EDGAR public filings. Always consult a qualified financial advisor before making investment decisions.

Last updated: Apr 22, 2026. Data sources: SEC EDGAR (financial statements), Yahoo Finance (market data, analyst consensus). Data may not reflect the most recent quarter.

KMB analysis methodology: How we calculate fair value, Z-Scores, and moat ratings